DAWN
Price
$6.87
Change
+$0.02 (+0.29%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
700.63M
47 days until earnings call
UTHR
Price
$438.34
Change
+$4.28 (+0.99%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
19.63B
35 days until earnings call
Interact to see
Advertisement

DAWN vs UTHR

Header iconDAWN vs UTHR Comparison
Open Charts DAWN vs UTHRBanner chart's image
Day One Biopharmaceuticals
Price$6.87
Change+$0.02 (+0.29%)
Volume$13.05K
Capitalization700.63M
United Therapeutics
Price$438.34
Change+$4.28 (+0.99%)
Volume$17.04K
Capitalization19.63B
DAWN vs UTHR Comparison Chart in %
Loading...
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DAWN vs. UTHR commentary
Sep 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DAWN is a Hold and UTHR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 25, 2025
Stock price -- (DAWN: $6.84 vs. UTHR: $434.06)
Brand notoriety: DAWN and UTHR are both not notable
DAWN represents the Biotechnology, while UTHR is part of the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: DAWN: 85% vs. UTHR: 138%
Market capitalization -- DAWN: $700.63M vs. UTHR: $19.63B
DAWN [@Biotechnology] is valued at $700.63M. UTHR’s [@Pharmaceuticals: Generic] market capitalization is $19.63B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DAWN’s FA Score shows that 1 FA rating(s) are green whileUTHR’s FA Score has 1 green FA rating(s).

  • DAWN’s FA Score: 1 green, 4 red.
  • UTHR’s FA Score: 1 green, 4 red.
According to our system of comparison, UTHR is a better buy in the long-term than DAWN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DAWN’s TA Score shows that 5 TA indicator(s) are bullish while UTHR’s TA Score has 5 bullish TA indicator(s).

  • DAWN’s TA Score: 5 bullish, 5 bearish.
  • UTHR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, UTHR is a better buy in the short-term than DAWN.

Price Growth

DAWN (@Biotechnology) experienced а -3.80% price change this week, while UTHR (@Pharmaceuticals: Generic) price change was +9.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was +10.70%, and the average quarterly price growth was +54.52%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.31%. For the same industry, the average monthly price growth was +26.40%, and the average quarterly price growth was +68.71%.

Reported Earning Dates

DAWN is expected to report earnings on Nov 10, 2025.

UTHR is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+4.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Generic (+6.31% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UTHR($19.6B) has a higher market cap than DAWN($701M). UTHR YTD gains are higher at: 23.019 vs. DAWN (-46.014). UTHR has higher annual earnings (EBITDA): 1.73B vs. DAWN (-108.37M). UTHR has more cash in the bank: 3.05B vs. DAWN (453M). DAWN has less debt than UTHR: DAWN (3M) vs UTHR (200M). UTHR has higher revenues than DAWN: UTHR (3.08B) vs DAWN (188M).
DAWNUTHRDAWN / UTHR
Capitalization701M19.6B4%
EBITDA-108.37M1.73B-6%
Gain YTD-46.01423.019-200%
P/E RatioN/A16.94-
Revenue188M3.08B6%
Total Cash453M3.05B15%
Total Debt3M200M2%
FUNDAMENTALS RATINGS
UTHR: Fundamental Ratings
UTHR
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
16
SMR RATING
1..100
47
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
42
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DAWNUTHR
RSI
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
62%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
60%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
69%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
68%
Advances
ODDS (%)
Bullish Trend 29 days ago
80%
Bullish Trend 6 days ago
72%
Declines
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 9 days ago
58%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
67%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DIPS6.100.05
+0.83%
YieldMax Short NVDA Option Inc Strgy ETF
JPRE47.720.35
+0.73%
JPMorgan Realty Income ETF
NEAR51.28N/A
N/A
iShares Short Duration Bond Active ETF
JANJ25.01N/A
N/A
Innovator Premium Income 30 Bar ETF -Jan
SHOC61.89-0.42
-0.68%
Strive U.S. Semiconductor ETF

DAWN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DAWN has been loosely correlated with DNLI. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if DAWN jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DAWN
1D Price
Change %
DAWN100%
+0.74%
DNLI - DAWN
50%
Loosely correlated
-2.03%
SYRE - DAWN
49%
Loosely correlated
+4.77%
NRIX - DAWN
48%
Loosely correlated
-2.25%
RVMD - DAWN
48%
Loosely correlated
-0.46%
OCUL - DAWN
47%
Loosely correlated
+0.41%
More

UTHR and

Correlation & Price change

A.I.dvisor indicates that over the last year, UTHR has been loosely correlated with DAWN. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if UTHR jumps, then DAWN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
+4.66%
DAWN - UTHR
40%
Loosely correlated
+0.74%
MNKD - UTHR
38%
Loosely correlated
-3.95%
GERN - UTHR
37%
Loosely correlated
+0.75%
CERO - UTHR
33%
Poorly correlated
-0.55%
UNCY - UTHR
32%
Poorly correlated
+0.51%
More